Company Filing History:
Years Active: 2008-2013
Title: Ehud Klein: Innovator in Schizophrenia Diagnosis
Introduction
Ehud Klein is a notable inventor based in Timrat, Israel, recognized for his contributions to the field of medical diagnostics. He holds two patents that focus on innovative methods for diagnosing schizophrenia, utilizing mitochondrial complex I as a biological marker.
Latest Patents
Klein's latest patents include methods and kits for the diagnosis of schizophrenia. These inventions provide a means to diagnose the condition by determining the levels of m-RNA or protein mitochondrial complex I subunits and assessing its activity through cellular basal respiration. In one embodiment, the method involves comparing the activity level of a mitochondrial complex I enzyme in a sample from a subject with a normative value. An altered level of activity indicates the potential presence of schizophrenia. Another embodiment focuses on measuring the levels of m-RNA or protein of mitochondrial complex I, with deviations from normative values suggesting the diagnosis of schizophrenia. The patents also disclose kits designed for this diagnostic purpose.
Career Highlights
Ehud Klein has worked with the Technion R&D Foundation Ltd., specifically in the Business Development and Financial Control Department. His experience in this organization has contributed to his expertise in the field of medical research and innovation.
Collaborations
Klein has collaborated with Dorit Ben-Shachar, enhancing his research and development efforts in the area of schizophrenia diagnosis.
Conclusion
Ehud Klein's innovative work in the diagnosis of schizophrenia through mitochondrial complex I represents a significant advancement in medical diagnostics. His contributions are poised to impact the understanding and treatment of this complex mental health condition.